Skip to main content

Articles

Page 1 of 17

  1. This study aims to investigate the potential role of Caprini risk assessment model (RAM) in predicting the risk of venous thromboembolism (VTE) in patients undergoing total hip or knee arthroplasty (THA/TKA). ...

    Authors: Zhencan Lin, Hao Sun, Meiyi Chen, Deng Li, Zhiqing Cai, Yimin Wang, Jie Xu and Ruofan Ma
    Citation: Thrombosis Journal 2024 22:68
  2. Thrombocytopenia frequently occurs in patients with sepsis. Disseminated intravascular coagulation (DIC) may be a possible cause of thrombocytopenia owing to its high prevalence and association with poor outco...

    Authors: Kasumi Satoh, Takeshi Wada, Akihito Tampo, Gaku Takahashi, Kota Hoshino, Hironori Matsumoto, Takayuki Taira, Satoshi Kazuma, Takamitsu Masuda, Takashi Tagami and Hiroyasu Ishikura
    Citation: Thrombosis Journal 2024 22:67
  3. This research is one of the pioneering randomized clinical trials (RCTs) aimed at assessing the effectiveness and safety of rivaroxaban in treating left ventricular thrombus (LVT) in patients who have experien...

    Authors: Pejman Mansouri, Zahra Azamian Jazi, Mohammad Hadi Mansouri, Hooman Dehghan, Reihaneh Zavar, Seyedeh Melika Hashemi, Fereshteh Sattar, Masoumeh Sadeghi, Afshin Amirpour and Morteza Abdar
    Citation: Thrombosis Journal 2024 22:66
  4. This study aimed to describe the status of antithrombotic therapy at discharge and prognosis in patients with atrial fibrillation (AF) and chronic coronary syndrome (CCS) who underwent percutaneous coronary in...

    Authors: Yimeng Wang, Yanmin Yang, Lulu Wang, Han Zhang, Jiang-shan Tan and Yuyuan Shu
    Citation: Thrombosis Journal 2024 22:65
  5. The association of low-density lipoprotein cholesterol (LDL-C) and lymphocyte counts with the development of deep vein thrombosis (DVT) has been demonstrated in many fields but remains lacking in open wedge hi...

    Authors: Haichuan Guo, Chengsi Li, Hao Wu, Meixin Ma, Ruoxuan Zhu, Maolin Wang, Bin Yang, Naihao Pan, Yanbin Zhu and Juan Wang
    Citation: Thrombosis Journal 2024 22:64
  6. Deep vein thrombosis (DVT) is common in patients undergoing gynecological surgery. We aimed to investigate the preventive efficacy in DVT of graduated compression stockings (GCS) alone and in combination with ...

    Authors: Limei Lu, Ya Shen and Yuping Pan
    Citation: Thrombosis Journal 2024 22:63
  7. Pulmonary embolism (PE) and deep venous thrombosis (DVT) are the two most important manifestations of venous thromboembolism (VTE). DVT remains a significant condition since associated morbidity is significant...

    Authors: Seble Birhane, Melak Gedamu Beyene, Fishatsion Tadesse and Assefa Mulu Baye
    Citation: Thrombosis Journal 2024 22:62
  8. Direct oral anticoagulants are the established drugs for treating pulmonary thromboembolism. The advantage of direct oral anticoagulants over conventional therapy for clot lysis and right ventricular unloading...

    Authors: Hiroya Hayashi, Akihiro Tsuji, Akiyuki Kotoku, Hiroyuki Endo, Naruhiro Nishi, Takatoyo Kiko, Ryotaro Asano, Jin Ueda, Tatsuo Aoki, Tetsuya Fukuda and Takeshi Ogo
    Citation: Thrombosis Journal 2024 22:60
  9. Routine coagulation tests are not widely accepted diagnostic criteria of trauma-induced hypercoagulopathy (TIH) due to insensitivity. Lymphatic vessels drain approximately 10% of the interstitial fluid into th...

    Authors: Yangkang Zheng, Pengyu Wang, Lin Cong, Qi Shi, Yongjian Zhao and YongJun Wang
    Citation: Thrombosis Journal 2024 22:59
  10. Mechanical thrombectomy (MT) has become the mainstay of treatment for acute ischemic stroke (AIS) recently. This case-control study aimed to identify the pivotal role of inflammation in the prognosis of AIS pa...

    Authors: Hong Wang, Xiaobing Tian, Zhangyuan Liao, Xuanye Yue, Libin Sun, Xingrong Li, Ming Zou and Jiayue Ding
    Citation: Thrombosis Journal 2024 22:58
  11. To identify recurrent venous thromboembolism (VTE) after discontinuation of anticoagulation in patients with isolated distal deep vein thrombosis based on its anatomic localization (axial or muscular veins).

    Authors: Wen-Tao Yang, Zhen-Yi Jin, Chun-Min Li, Jia-Hao Wen and Hua-Liang Ren
    Citation: Thrombosis Journal 2024 22:57
  12. Hypercoagulability emerges as a central pathological feature and clinical complication in nephrotic syndrome. Increased platelet activation and aggregability are closely related to hypercoagulability in nephro...

    Authors: Shi-Ping Na, Mei-Liang Ning, Ji-Fang Ma, Shuang Liang, Yan-Li Wang, Man-Shu Sui, Xiao-Fang Guo, Ying Ji, Hui-Yan Lyu, Xue-Ying Yuan and Yu-Shi Bao
    Citation: Thrombosis Journal 2024 22:56
  13. In recent years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in critically ill patients with respiratory or cardiac failure. Heparin is usually used as anticoagulation therapy during ...

    Authors: Danyu Song, Yu Jin, Yang Zhang and Zhou Zhou
    Citation: Thrombosis Journal 2024 22:55
  14. Tuberculosis disease (TB) and tuberculosis infection (TBI) have been associated with increased risk of cardiovascular disease which may be connected to infection-related haemostatic changes. It is unknown if t...

    Authors: Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop and Pernille Ravn
    Citation: Thrombosis Journal 2024 22:54
  15. Platelet is enriched with Circular RNAs (circRNAs), with circFAM13B rank among the 10 most abundant circRNAs in platelets. The aim of the present study was to evaluate the predictive value of platelet-derived ...

    Authors: Yuting Zou, Yuyan Wang, Yanzhu Yao, Yangxun Wu, Chao Lv and Tong Yin
    Citation: Thrombosis Journal 2024 22:53
  16. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact, with millions of confirmed cases and deaths worldwide...

    Authors: Kiyohito Hayashi, Daisuke Koyama, Yoichi Hamazaki, Takamichi Kamiyama, Shingo Yamada, Miki Furukawa, Yoshinori Tanino, Yoko Shibata and Takayuki Ikezoe
    Citation: Thrombosis Journal 2024 22:52
  17. The link between venous thromboembolism (VTE) and cancer is well known. VTE could be the initial sign of an occult malignancy. There are more diagnoses of cancer after an unprovoked VTE compared to a provoked ...

    Authors: Maria-Cristina Glodeanu, Victoria Mutruc, Camelia-Maria Apetrei, Manuela Ursaru, Laurentiu Sorodoc and Catalina Lionte
    Citation: Thrombosis Journal 2024 22:51
  18. About 13–25% of cerebral venous thrombosis (CVT) cases lack clear etiology, which may be associated with underlying genetic factors. This study aims to investigate genetic factors in CVT patients using whole e...

    Authors: Shaoying Wang, Ming Yao, Xinzhuang Yang, Yicheng Zhu and Bin Peng
    Citation: Thrombosis Journal 2024 22:50
  19. Pulmonary embolism (PE) is a life-threatening thromboembolic disease for which there is limited evidence for effective prevention and treatment. Our goal was to determine whether genetically predicted circulatin...

    Authors: Chen Jiang, Jianing Lin, Bin Xie, Meijuan Peng, Ziyu Dai, Suyin Mai and Qiong Chen
    Citation: Thrombosis Journal 2024 22:49
  20. Risks of recurrence and major bleeding with extended anticoagulation in Asian patients with venous thromboembolism (VTE) are similar to those in non-Asian patients but risks according to baseline risk factor p...

    Authors: Norikazu Yamada, Weiguo Fu, Zhenyu Shi, Ki-Hyuk Park, Hyo-Soo Kim, Xiangchen Dai, Anthonie WA Lensing, Akos F Pap, Tomoko Kohno, Tsubasa Tajima, Tadashi Watakabe and Tomoyuki Mitsumori
    Citation: Thrombosis Journal 2024 22:48
  21. Von Willebrand factor (vWF) plays a crucial role in hemostasis, acting as a key factor for platelet adhesion/aggregation and as a transport protein for coagulation factor VIII. vWF is secreted as a giant multi...

    Authors: Yuki Chiba, Kota Goto, Misako Suzuki, Hisanori Horiuchi and Mineji Hayakawa
    Citation: Thrombosis Journal 2024 22:46
  22. Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures. Thus, we aim to estimate CDSS efficacy to optimize adherence to oral anticoagulant...

    Authors: Ahmed Mazen Amin, Ramy Ghaly, Mohamed T. Abuelazm, Ahmed A. Ibrahim, Mohammad Tanashat, Moumen Arnaout, Obieda Altobaishat, Ahmed Elshahat, Basel Abdelazeem and Sudarshan Balla
    Citation: Thrombosis Journal 2024 22:45
  23. Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently investigating the use of Apixaban in un...

    Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Hadeel Alkofide, Manal A. Aljohani, Hisham A. Badreldin, Mahasen Al Harbi, Ghalia Aquil, Raghad Alhajaji, Rahaf A. Alqahtani, Alaa Babonji, Maha Altuwayr, Asma A. Alshehri, Mashael Alfaifi, Abdullah F. Alharthi, Mohammed Alzahrani, Tareq Al Sulaiman…
    Citation: Thrombosis Journal 2024 22:43
  24. This study aimed to evaluate the association of antiphospholipid antibodies (aPL) and conventional markers of coagulation with ischemic and bleeding risk in patients with atrial fibrillation (AF) undergoing pe...

    Authors: Diona Gjermeni, Viktoria Anfang, Sofia Szabó, Hannah Vetter, Ana C. Venhoff, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Martin Buechsel, Dirk Westermann and Christoph B. Olivier
    Citation: Thrombosis Journal 2024 22:42
  25. Currently published studies have not observed consistent results on the efficacy and safety of direct oral anticoagulants (DOACs) use in patients with chronic kidney disease (CKD) combined with atrial fibrilla...

    Authors: Yaodi Li, Shuyi Wu, Jintuo Zhou and Jinhua Zhang
    Citation: Thrombosis Journal 2024 22:40
  26. The management of acute pulmonary embolism (PE) has become increasingly complex with the expansion of advanced therapeutic options, resulting in the development and widespread adoption of multidisciplinary Pul...

    Authors: Tiffany A. Gardner, Alexandra Fuher, August Longino, Eric M. Sink, James Jurica, Bryan Park, Jonathan Lindquist, Todd M. Bull and Peter Hountras
    Citation: Thrombosis Journal 2024 22:38
  27. Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused.

    Authors: Mirjana Mitrovic, Nikola Pantic, Zoran Bukumiric, Nikica Sabljic, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Nikola Ilic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Jecko Thachil and Darko Antic
    Citation: Thrombosis Journal 2024 22:37
  28. In this report, we report a case of a middle-aged male, admitted to the ICU with cerebral hemorrhage resulting from a severe high-altitude fall. The patient encountered significant challenges in oxygenation in...

    Authors: Lijie Wang, Chengyong Ma, Luping Wang, Qianrong Ding, Hao Yang, Bo Wang and Qin Wu
    Citation: Thrombosis Journal 2024 22:36
  29. Older individuals and, in particular, individuals at risk of recurrent stroke, may be susceptible to thrombosis when participating in exercise, however, this aspect has not been well investigated.

    Authors: L. B. Nørregaard, K. A. Wickham, J. S. Jeppesen, N. Rytter, L. C. Christoffersen, L. Gliemann, M. Lawrence, P. A. Evans, C. Kruuse and Y. Hellsten
    Citation: Thrombosis Journal 2024 22:35
  30. To investigate the genetic underpinnings of the association between type 2 diabetes (T2D), glycemic indicators such as fasting glucose (FG), fasting insulin (FI), and glycated hemoglobin (GH), and venous throm...

    Authors: Mingyi Yang, Xianjie Wan, Yani Su, Ke Xu, Pengfei Wen, Binfei Zhang, Lin Liu, Zhi Yang and Peng Xu
    Citation: Thrombosis Journal 2024 22:33
  31. Antiphospholipid syndrome (APLS) is a systemic immune dysregulation distinguished by repetitive complications and pregnancy loss in the absence of definite etiology. Most research focuses on the laboratory det...

    Authors: Shams ElDoha Galal ElDin Zaiema, Menna Allah Zakaria Mohammad Ali Abou Elwafa, Shaymaa Gamal Arafa Hassan, Radwa Hassan Abou El Fotoh El Adwey, Raghda Mohammed Mostafa Ghorab and Raghda El Sayed Abdel Monem Galal
    Citation: Thrombosis Journal 2024 22:32
  32. The International Medical Prevention Registry for Venous Thromboembolism (IMPROVE) Bleeding Risk Score is the recommended risk assessment model (RAM) for predicting bleeding risk in acutely ill medical inpatie...

    Authors: Daichi Arakaki, Mitsunaga Iwata and Teruhiko Terasawa
    Citation: Thrombosis Journal 2024 22:31
  33. Thromboembolic complications are well known in the treatment of childhood acute lymphoblastic leukemia. Over the years it has not been possible to reach a consensus on a possible prophylaxis of thromboembolic ...

    Authors: Christina Salvador, Robert Salvador, Gabriele Kropshofer, Bernhard Meister, Marie Rock, Petra Obexer, Benjamin Hetzer, Evelyn Rabensteiner and Roman Crazzolara
    Citation: Thrombosis Journal 2024 22:30
  34. Thrombosis in ANCA-associated vasculitis (AAV) was prevalent and has been neglected in Chinese patients. This study tried to describe the clinical characteristics, identify the risk factors, and investigate th...

    Authors: Xin Chen, Shuo Zhang, Ruilian You, Yixin Ma, Peng Xia, Xiaoxiao Shi, Haiting Wu, Ke Zheng, Yan Qin, Xinping Tian and Limeng Chen
    Citation: Thrombosis Journal 2024 22:29
  35. C-type lectin-like receptor-2 (CLEC-2) is a member of the C-type lectin superfamily of cell surface receptors. The first confirmed endogenous and exogenous ligands of CLEC-2 are podoplanin and rhodocytin, resp...

    Authors: Lan Sun, Zhe Wang, Zhiyan Liu, Guangyan Mu, Yimin Cui and Qian Xiang
    Citation: Thrombosis Journal 2024 22:27
  36. Analyses of extensive, nationally representative databases indicate a rising prevalence of venous thromboembolism (VTE) among critically ill children. However, the majority of studies on childhood VTE have pri...

    Authors: Jintuo Zhou, Yanting Zhu, Ying Liu, Hairong Zhan, Peiguang Niu, Huajiao Chen and Jinhua Zhang
    Citation: Thrombosis Journal 2024 22:26
  37. The retrieval of inferior vena cava (IVC) filter is essential for preventing complications associated with the device. Advanced techniques have been developed to improve the success rate of retrieving tip-embe...

    Authors: Yang Liu, Junlong Ma, Qiqi Wang, Wei Zeng and Chunshui He
    Citation: Thrombosis Journal 2024 22:25
  38. There are situations where information about the anticoagulant effects of Rivaroxaban could be clinically useful. Methods for measuring Rivaroxaban concentrations are not available at all medical laboratories ...

    Authors: Liselotte Onelöv, Elvar Theodorsson, Mojca Božič-Mijovski† and Alenka Mavri
    Citation: Thrombosis Journal 2024 22:24
  39. Left ventricular thrombus (LVT) formation in patients with acute myocardial infarction (AMI) or cardiomyopathies is not uncommon. The optimal oral anticoagulation therapy for resolving LVT has been under inten...

    Authors: Tong Hu, Changli Chen, Kellina Maduray, Wenqiang Han, Tongshuai Chen and Jingquan Zhong
    Citation: Thrombosis Journal 2024 22:23
  40. There is substantial evidence to support the use of several methods for preventing deep-vein thrombosis (DVT) following intracerebral hemorrhage (ICH). However, the extent to which these measures are implement...

    Authors: Ran Zhang, Weige Sun, Yana Xing, Yongjun Wang, Zixiao Li, Liping Liu, Hongqiu Gu, Kaixuan Yang, Xin Yang, Chunjuan Wang, Qingbo Liu, Qian Xiao and Weixin Cai
    Citation: Thrombosis Journal 2024 22:22
  41. This study aimed to analyze the independent risk factors contributing to preoperative DVT in TKA and constructed a predictive nomogram to accurately evaluate its occurrence based on these factors.

    Authors: Zehua Wang, Xingjia Mao, Zijian Guo, Guoyu Che, Changxin Xiang and Chuan Xiang
    Citation: Thrombosis Journal 2024 22:21
  42. Inherited thrombophilia (IT) has a complex pathophysiology and is associated with recurrent miscarriage (RM) by causing placental insufficiency and inhibiting fetal development. However, thrombophilia screenin...

    Authors: Ayman A. Najjar, Imam Hassouna, Mahmoud A. Srour, Hany M. Ibrahim, Randa Y. Assi and Heba M. Abd El Latif
    Citation: Thrombosis Journal 2024 22:20
  43. Antithrombin (AT) is an important anticoagulant in hemostasis. We describe here the characterization of a novel AT mutation associated with clinically relevant thrombosis. A pair of sisters with confirmed type...

    Authors: Maximilian Ruf, Sarah Cunningham, Alexandra Wandersee, Regine Brox, Susanne Achenbach, Julian Strobel, Holger Hackstein and Sabine Schneider
    Citation: Thrombosis Journal 2024 22:19

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.653
    SCImago Journal Rank (SJR): 0.572

    Speed 2023
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 107

    Usage 2023
    Downloads: 708,004
    Altmetric mentions: 943